Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 9 of 9 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company APIE Therapeutics Inc. | Activity: Research and Development | Company Description APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. | Location Research Triangle Park | |
Company Avior Inc. | Activity: Research and Development | Company Description Avior is a clinical-stage pharmaceutical company developing treatments for patients suffering from chronic liver disease (CLD) associated pruritus and pruritus in atopic dermatitis. | Location Cary | |
Company Dignify Therapeutics LLC | Activity: Research and Development | Company Description Dignify Therapeutics develops novel bowel and bladder therapies for people with neurological disorders and the elderly that suffer from incontinence. | Location Research Triangle Park | |
Company Endacea Inc. | Activity: Research and Development | Company Description Endacea develops A1 adenosine receptor antagonists as drug candidates for cancer, COVID-19 acute lung injury, sepsis and acute renal failure. | Location Research Triangle Park | |
Company Levee Medical Inc. | Activity: Research and Development | Company Description Levee Medical designs, develops and manufactures innovative urological devices to improve recovery outcomes of patients following radical prostatectomy. | Location Durham | |
Company MD Scientific LLC | Activity: Research and Development | Company Description MD Scientific developed the EndoTool Glucose Management System and is currently developing a drug to prevent kidney and heart injury from iodinated contrast agents. | Location Charlotte | |
Company Pathalys Pharma Inc. | Activity: Research and Development | Company Description Pathalys Pharma develops therapeutics that address unmet needs in the management of end stage kidney disesase (ESKD). | Location Raleigh | |
Company Praetego Inc. | Activity: Research and Development | Company Description Praetego is preclinical stage pharmaceutical company committed to improving health outcomes by addressing chronic diseases of aging, starting with Alzheimer’s Disease. Praetego’s novel small molecules inhibit a systemic driver of oxidative stress at the initiation of pathology. | Location Research Triangle Park | |
Company URO-1 Inc. | Activity: Research and Development | Company Description URO-1 develops breakthrough products for office procedures for urology and urogynecology, which improve clinical outcomes, enhance patient experience and increase procedure efficiency. | Location Greensboro |